Intended for UK patients and members of the public
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintProduct Documentation
Last updated on this site: 16 Sep 2025
Description of update:
SmPC sections 4.2, 4.4, 4.5, 4.6, 4.8, 5.1 and 5.2 for the above-listed MAs have been updated in line with the reference product Crestor 5mg, 10mg, 20mg and 40mg film-coated tablets NL/H/0343/001-004, Grünenthal B.V. Dated Sep 2024. Consequently, the PIL has been updated.
Additionally, SmPC section 6.1 and PIL section 6 have been updated to remove the word ‘anhydrous’ in line with the ninth edition EP.
Date of approval: 08/09/2025
SmPC sections updated: 4.2, 4.4, 4.5, 4.6, 4.8, 5.1, 5.2, 6.1 and 10
Last updated on this site: 16 Sep 2025
SmPC sections 4.2, 4.4, 4.5, 4.6, 4.8, 5.1 and 5.2 for the above-listed MAs have been updated in line with the reference product Crestor 5mg, 10mg, 20mg and 40mg film-coated tablets NL/H/0343/001-004, Grünenthal B.V. Dated Sep 2024. Consequently, the PIL has been updated.
Additionally, SmPC section 6.1 and PIL section 6 have been updated to remove the word ‘anhydrous’ in line with the ninth edition EP.
Date of approval: 08/09/2025
SmPC sections updated: 4.2, 4.4, 4.5, 4.6, 4.8, 5.1, 5.2, 6.1 and 10
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintFor any further assistance, please get in touch.